Incannex Healthcare (IXHL) Times Interest Earned (2023 - 2026)
Incannex Healthcare (IXHL) posted quarterly Times Interest Earned of -$32.91 for Q1 2026, down 109.19% year-on-year from $358.28 in Q1 2025, and up 17.19% on a QoQ basis from -$39.74 in Q4 2025.
Incannex Healthcare (IXHL) Times Interest Earned (2023 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Times Interest Earned for 4 consecutive years, with -$32.91 the latest figure, recorded in Q1 2026.
- Quarterly Times Interest Earned fell 109.19% year-over-year to -$32.91 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$206.22 (down 152.17% YoY) and the FY2025 annual result came in at -$78.51, down 44851.86% from the prior year.
- Times Interest Earned improved to -$32.91 in Q1 2026 per IXHL's latest filing, from -$39.74 in the prior quarter.
- Over the last five years, Times Interest Earned for IXHL reached as high as -$0.06 in Q2 2024 and fell as low as -$39.74 in Q4 2025.
- A 4-year average of -$19.27 and a median of -$13.89 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned jumped 99.8% — and 2025, when it plunged 188.31%.
- Year by year, Times Interest Earned stood at -$13.11 in 2023, then retreated by 5.16% to -$13.79 in 2024, then sank by 188.31% to -$39.74 in 2025, then advanced by 17.19% to -$32.91 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$32.91, -$39.74, and -$29.93 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | -32.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.91 |
| Dec 31, 2025 | -39.74 |
| Sep 30, 2025 | -29.93 |
| Mar 31, 2025 | -15.73 |
| Dec 31, 2024 | -13.79 |
| Sep 30, 2024 | -13.66 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -13.89 |
| Dec 31, 2023 | -13.11 |
| Sep 30, 2023 | -11.07 |
| Jun 30, 2023 | -28.15 |